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Abstract: Mohs micrographic surgery (MMS) is a precise technique where layers of tissue are 
resected and examined with intraoperative histopathology to minimize the removal of normal 
tissue while completely excising the cancer. To achieve intraoperative pathology, the tissue is 
frozen, sectioned and stained over a 20- to 60-minute period, then analyzed by the MMS 
surgeon. Surgery is continued one layer at a time until no cancerous cells remain, meaning 
MMS can take several hours to complete. Ideally, it would be desirable to circumvent or 
augment frozen sectioning methods and directly visualize subcellular morphology on the 
unprocessed excised tissues. Employing photoacoustic remote sensing (PARS™) microscopy, 
we present a non-contact label-free reflection-mode method of performing such visualizations 
in frozen sections of human skin. PARS leverages endogenous optical absorption contrast 
within cell nuclei to provide visualizations reminiscent of histochemical staining techniques. 
Here, we demonstrate the ability of PARS microscopy to provide large grossing scans (>1 cm2, 
sufficient to visualize entire MMS sections) and regional scans with subcellular lateral 
resolution (400 ± 150 nm). 
 
  
1. Introduction 
Mohs micrographic surgery (MMS) is the gold standard precision surgical technique for 
treating contiguous invading skin cancers in cosmetically and functionally important areas [1]. 
MMS excision of nonmelanoma skin cancers (NMSC) represents one of the most common 
procedures in the United States. Around 25% of the 3.5 million NMSC cases diagnosed each 
year are treated with this procedure [2,3].  In recent years NMSC incidence has risen 
dramatically, straining the global capacity to provide MMS [2].  For the two most common 
NMSCs, basal cell carcinomas (BCC) and squamous cell carcinomas (SCC), MMS achieves a 
five-year cure rate of nearly 99% [4,5]. For high risk nonmelanoma lesions, MMS achieves 
higher cure rates than wide local excision [6-8]. MMS repeatedly excises thin tissue layers that 
then undergo intraoperative histopathological analysis to identify regions of invasion at the 
margins. During MMS, the surgeon will excise successive shallow layers of tissue capturing a 
2 to 3 mm margin around the tumor [9]. The excised tissue sample undergoes frozen sectioning 
and histochemical staining to permit transmission light microscopic assessment. In contrast to 
other surgical techniques, in MMS the entire deep and peripheral margin of the excised tissue 
undergoes pathological analysis. By assessing the entire surgical margin in this manner, the 
surgeon is able to identify specific invasive regions of malignant cells. This process of layer by 
layer excision with interim histopathological analysis is repeated until the entire invasive tumor 
has been removed [9].  
The use of intraoperative frozen histology means operating times for MMS can exceed 
several hours, depending on the number of excisions required [10]. Most of this time is 
consumed by tissue processing, which requires 30 to 60 minutes per tissue layer, while the 
excision and pathologic assessment are relatively rapid [9]. Consequently, the rate limiting step 
in the MMS process is generating the tissue suitable for transmission light microscopic 
interpretation. The MMS process could be accelerated greatly if tissue processing could be 
circumvented, and unstained tissues visualized directly. Ideally, images so obtained would be 
visually similar to standard histochemical staining images. Furthermore, this would also 
preserve sample integrity permitting re-examination and additional immunochemistry analysis.  
Direct histological imaging of unstained tissue sections presents unique challenges 
compared to pathological analysis of stained frozen preparations. Nonetheless, a variety of 
imaging methods have demonstrated histology-like imaging in MMS excisions. Prominent 
examples include microscopy with ultraviolet surface excitation (MUSE) [11], multiphoton 
fluorescence microscopy (MPM) [12,13], Raman spectroscopy [14-16], photoacoustic 
microscopy (PAM) [17,18], and optical coherence tomography (OCT) [19-21], each of which 
has been explored for intraoperative histology for MMS. While MUSE and MPM have shown 
promising histology-like images, they require exogenous dyes for contrast. Staining tissues 
prior to imaging reintroduces many of the tissue preparation issues experienced by frozen 
histology, as staining can be resource intensive and complex, and introduces a potential for 
variability. Of the above techniques then, Raman spectroscopy, PAM and OCT are the only 
modalities demonstrating label-free histology-like imaging of MMS specimens [14-21].  
Considering the potential imaging techniques, PAM [17,18], Raman spectroscopy [14-16] 
and OCT [19-21] histopathology all provide resolutions significantly inferior to conventional 
optical microscopy. Applied in-vivo, both PAM [17,18] and Raman spectroscopy [14-16] fail 
to provide subcellular resolution. Hence, both techniques are inadequate for precisely locating 
small and subtle regions of malignant cells. These modalities are then inappropriate for MMS 
where nuclear morphology of the entire deep and peripheral margin of the excised tissue must 
be assessed. While OCT, provides subcellular resolution the optical scattering contrast in OCT 
does not provide the specificity necessary to match current pathology standards [19-21]. To 
provide visualizations reminiscent of current H&E staining, OCT systems must use external 
image processing techniques. Therefore, there remains a pressing need for an accurate 
interoperative label-free histopathological microscopy technique capable of imaging large areas 
of tissue while also providing subcellular resolution to expedite MMS procedures. 
Photoacoustic Remote Sensing (PARS™) microscopy has recently emerged as an all-
optical non-contact label-free reflection-mode imaging modality [22-24]. Like other 
photoacoustic techniques, PARS captures endogenous optical absorption contrast visualizing a 
wide range of biological chromophores including hemoglobin, lipids, and DNA. A pulsed 
excitation laser is used to deposit optical energy into the sample. As the target chromophore 
absorbs the excitation pulse, it undergoes thermo-elastic expansion proportional to the absorbed 
excitation energy. The expansion induces nanosecond scale modulations in the local refractive 
index of the sample. In PARS, this effect is observed as back-reflected intensity variations of a 
second co-focused continuous-wave detection laser. In this way, PARS microscopy visualizes 
endogenous absorption contrast in an all-optical label-free reflection-mode architecture [22-
24].  Previously, our group has shown promising histology-like imaging capabilities by 
utilizing ultraviolet excitation to primarily target the absorption contrast of DNA [23,24]. 
Accentuating this contrast generates visualizations reminiscent of immunohistochemical 
staining of cell nuclei. In recent works, PARS histological imaging has been applied in thick 
tissue samples (>2 mm) including freshly resected tissues and formalin fixed paraffin 
embedded tissue preparations [23,24].   
In this work, we present a PARS system for rapid label-free histological imaging of 
unprocessed MMS sections. By leveraging recent technical improvements of the PARS system, 
we have expanded the histological imaging capabilities to match the scanning area, resolution 
and imaging speed required for MMS. We show the first non-contact photoacoustic microscopy 
of Mohs excisions. Wide field of view grossing scans capture entire MMS sections (>1 cm2 
area) with sufficient resolution to recover subcellular diagnostic characteristics. Concurrently, 
smaller high-resolution images give close-ups of clinically relevant regions. These small fields 
provide 400 ± 150 nm optical resolution enabling morphological assessment of single nuclei. 
Thus, the proposed PARS system provides both the grossing scan capabilities, and high spatial 
resolution required to assess tissues during MMS. Compared to frozen histology, the presented 
PARS microscope without optimized scanning hardware can image an entire MMS excision in 
under 12 minutes, 60% of the time for standard MMS tissue preparation. Applied in a clinical 
setting, this device may circumvent the need for histopathological processing of tissue. Thus, 
PARS is well positioned to supplement existing intraoperative tissue analysis techniques, 
potentially reducing the time for each MMS operative cycle, streamlining the MMS process, 
thereby increasing MMS capacity.   
 
2. Methods 
2.1 Imaging System: 
  
Fig. 4. Simplified Schematic of the PARS system. Component labels are defined as follows: collimator (COL), 
polarizing beam splitter (PBS), quarter wave plate (QWP), dichroic mirror (DM), variable beam expander (VBE), beam 
dump (BD), objective lens (OL), long pass filter (LP), aspheric focal lens (AL), photodiode (PD),  analogue high-pass 
filter (A-HPF), mirrors (M).  
 
The proposed imaging system is shown in Figure 1. A 400 ps pulsed laser (WEDGE XF, 
Bright Solutions) was selected to provide 266 nm UV excitation. Residual 532 nm output is 
removed from the excitation beam with a CAF2 prism (PS862, Thorlabs). Following 
separation, the UV beam is expanded (BE05-266, Thorlabs) and combined with the detection 
beam via dichroic mirror (HBSY234, Thorlabs). Detection of PARS signals is performed with 
a 1310 nm continuous wave super-luminescent diode (S5FC1018P, Thorlabs). Collimated, 
horizontally polarized detection light passes through a polarizing beam splitter (PBS254, 
Thorlabs) and quarter wave plate (WPQ10M-1310, Thorlabs) into the imaging system. Both 
excitation and detection are then co-focused onto the sample with a 0.5 NA reflective objective 
(LMM-15X-UVV, Thorlabs).  The back reflected detection beam from the sample which 
encodes the PARS modulations, is returned along detection pathway. Passing through the 
quarter wave plate for a second time, the detection beam becomes horizontally polarized. The 
horizontally polarized light is then directed towards the photodetector by the polarizing beam 
splitter where it is filtered (FELH1000, Thorlabs) before being focused onto the photodiode 
(PDB425C-AC, Thorlabs). 
Images were collected by mechanically scanning samples over the fixed imaging head in 
a continued raster pattern. While scanning, the excitation laser pulses continually capturing 
evenly spaced PARS interrogation points. The lateral spacing between PARS collection points 
is then tuned by adjusting the stage speed and excitation laser repetition rate. Depending on the 
desired resolution, the lateral spacing ranged from 0.1 to 5 µm. Each time the excitation laser 
is pulsed, a short segment of photodetector signal is recorded capturing the PARS modulations. 
To ensure accurate recovery of the PARS interrogation, around 250 samples of the photodiode 
signal are captured with a 14-bit digitizer (RZE-004-300, Gage Applied). This time domain 
data is streamed via PCI-E channel from the digitizer to the computer memory. Here, an 
algorithm was applied to extract the characteristic amplitude of each PARS signal in real time. 
The image is then reconstructed by imposing the collected data on a Cartesian grid [23,24].  
 
2.2 Sample Preparation: 
In this study, a variety of MMS excisions with BCC were selected for imaging. Frozen 
sections of tissue specimens with BCC were obtained from Mohs surgeries. The Mohs 
excisions are embedded within a cutting substrate and placed into a cryostat where they are 
cooled to approximately -25°C, over a 1 to 10-minute period (depending on sample shape and 
composition). The frozen samples were then sectioned via cryotome into 5-10-micron slices 
and placed onto a microscope slide. The slide was then dried and fixed at 55°C for 1 minute. 
Two sections were collected and fixed from each tissue sample, the outermost section was 
stained with toluidine blue, while the inner section was kept unstained. The toluidine blue 
staining was performed with 1% toluidine blue aqueous solution, a standard protocol for BCC. 
Once stained, the slides were covered with mounting media. The tissue samples were collected 
under protocols approved by the Research Ethics Board of Alberta (Protocol ID: HREBA.CC-
18-0277) and the University of Waterloo Health Research Ethics Committee (Humans: 
#40275). The ethics committees waived the requirement for patient consent as the selected 
samples were excess tissues no-longer required for diagnostic purposes, and no patient 
identifiers were provided to the researchers. All experiments were performed in accordance 
with the requirements of the Government of Canada Panel on Research Ethics Guidelines. 
 
3. Results and Discussion 
Results of large grossing scans are shown in Figure 2. Figure 2a and 2b feature large field 
of view scans of a human MMS excision with BCC (13 mm and 10 mm side lengths 
respectively). In each case, dense regions of tumor tissues are observed within the excised 
tissues. Moreover, the bulk tissue morphology and the surgical margins can be assessed readily. 
A region of hypercellularity is seen extending and infiltrating into normal skin tissue (Figure 
2a). Further resection layer shows only normal skin tissue (Figure 2b) with hair follicles being 
visible.  
 
 
   
Fig. 2. Wide field of view PARS images of entire Mohs excisions. a) 13 mm by 13 mm PARS image of human skin 
tissue with basal cell carcinoma shown by the increased cellularity in the middle (deep) margin causing invasion and 
architectural distortion of the normal skin (scale Bar: 2 mm). b) 10 mm by 10 mm PARS image of human skin tissue 
(scale Bar: 1 mm). Both a & b feature a 4 µm lateral step size. 
 
Assessing the entire excision surface is crucial to the high success of MMS compared to 
other techniques. Observing the entire surgical margin means areas of contiguous invasion can 
be identified for excision. By necessity, tissue sections exceeding 1.0 cm2 in area, such as the 
scans presented in Figure 2, must be imaged with subcellular resolution.  Moreover, to improve 
on frozen sectioning, imaging must be performed in under 20 minutes. Ideally the imaging time 
should be further reduced, to under 10 minutes. Several technical improvements have been 
made over previous reports of PARS devices to match the scanning area, resolution and 
imaging speed required for MMS. These have included improvements to scanning accuracy, 
imaging speed, image reconstruction techniques, data management, and system sensitivity.  By 
the nature of the point scanning mechanism, these improvements have enhanced both the 
grossing scans and small field scans. At each scale, (large or small scan window) the number 
of interrogation points may remain the same, however, the excitation rate and/or mechanical 
scanning speed may be scaled up or down to provide the desired lateral step size and resolution. 
Increasing the scan area is usually accompanied by a corresponding reduction in resolution 
or an increase in acquisition time. Fortunately, in PARS, the impacts on resolution and imaging 
speed may be mostly mitigated by selecting a sufficiently high excitation laser repetition rate. 
However, increasing the repetition rate while maintaining the same spatial sampling rate also 
necessitates an increase in the movement speed of the scanning stages. In the proposed system, 
these stages are limited to a maximum velocity of 200 mm/s. Thus, for the grossing scans 
displayed in Figure 2 a and b, maintaining 4 µm spatial sampling requires a repetition rate of 
50 kHz. Operating at the maximum mechanical velocity and 50 kHz excitation, a 16-million-
point scan similar to Figure 3, or Figure 4, could be captured in roughly 12 minutes. Moving 
forwards, the imaging time will be drastically reduced by exchanging the mechanical stages 
and excitation laser. Utilizing a commercially available 600 mm/s mechanical stage in 
conjunction with a with a 1 MHz excitation would reduce the imaging time from 12, to under 
2 minutes. However, another issue arises as capturing images such as Figure 2, or Figure 3 (16-
million-points/image) would potentially result in nearly 30 GB of data for a single capture. To 
circumvent this issue, an algorithm was applied to extract the characteristic amplitude of each 
PARS signal in real time. Thus, the memory requirement is reduced by around 256 times. As a 
result, the number of PARS signals which can be reasonably recovered in a single scan is 
increased by the same factor, enabling practical acquisition of the presented larger and/or higher 
resolution scans.  
Compared to the wide field images in Figure 2, the tighter spatial sampling and smaller field 
of view in Figure 3 reveal more intricate tissue morphology. By reducing the lateral spatial 
sampling rate to 250 nm, we achieve an optically limited resolution of 400 ± 150 nm. Presented 
in Figure 3 is a series of high-resolution PARS images of a tissue sample with BCC (bottom 
(ii)). Images of a similar tissue region prepared with standard frozen histology sectioning and 
toluidine blue staining are shown across the top row (i) of Figure 3. The toluidine blue dye in 
Figure 3 is commonly used in MMS for assessing NMSC.  It should be noted that while the 
unstained and stained slices are adjacent, there are differences in bulk structure as these sections 
are 5-10 µm thick. Within the images, the margin of invasive disease is identified due to high 
cellularity and corresponding nuclear content on PARS imaging, which corresponds to the light 
microscopy images. The nuclear atypia and disorganized cellular organization are indicative of 
the presence of cancerous tissue.  
 
  
 
Fig.3 Comparison of PARS and bright-field images of toluidine blue (TB) stained human skin tissue with basal cell 
carcinoma (BCC). a) (i) 5x bright field image of tissue with BCC. (ii) PARS image of an adjacent unstained sample 
with BCC. Scale Bar: 200 µm b) (i) 20x bright field image demonstrating the border of invasive cancer (bottom) versus 
normal tissue (top). (ii) Enlarged section (red box) of the PARS image (a.ii) compares the disorganized cellular 
architecture seen in the light microscopy and PARS images. Scale Bar: 100 µm c) (i) 20x bright field of tissue with 
clearly identifiable atypical nuclear morphology, size and distribution. (ii) Enlarged section (green box) of the PARS 
image (b.ii). Scale Bar: 40 µm. NOTE: While the unstained and stained slices are adjacent, there are differences in 
bulk structure as the sections are 5-10 µm thick. 
 
Presented in Figure 4a is a series of 4 smaller 1 mm2 images co-registered to form a 4 mm 
x 1 mm image with resolution equivalent to Figure 3. Each individual frame is 28 megapixels, 
4000 by 7000-point image. Shown in this image is the transition from cancerous tissue to 
normal tissue at the tumor margin. The ability to identify this tumor margin will guide the MMS 
surgeon in resecting the next layer of tissue. 
 
  
 
Fig. 4.  Large area high resolution PARS image of human skin tissue with basal cell carcinoma. (a) A series of four 
PARS images stitched together (112-megapixel image, 16000 by 7000-point scan, 250 nm step size) with 
hypercellularity and nuclear content giving high PARS signal along with evident disorganized cellular architecture 
denoting cancerous tissue seen in the bottom left and normal tissue in the top and right. Scale Bar: 400 μm (b) Cropped 
and enlarged section (red box) of the PARS image shown in (a) Scale Bar: 100 μm (c) Cropped and enlarged section 
(blue box) of the PARS image shown in (a) Scale Bar: 100 μm (d) Cropped and enlarged section (green box) of the 
PARS image shown in (a) Scale Bar: 100 μm 
 
While the UV absorption of DNA is orders of magnitude higher than surrounding 
chromophores, most common biomolecules have non-zero optical absorption of UV. As a 
result, subtle contrast attributed to biomolecules, such as cytochrome, hemoglobin and collagen 
can be recovered by applying non-linear scaling to the absorption data. Such extranuclear 
details are observed in Figure 4. To accentuate these subtle details, the PARS optical system 
was refined to ensure maximum detection sensitivity. While these refinements have enhanced 
non-nuclear contrast, the extranuclear chromophores cannot be individually identified as their 
UV absorptions are relatively similar. However, recovering bulk tissue contrast from 
extranuclear structures still imparts a visualization benefit, as bulk tissue morphology may be 
captured in addition to nuclear contrast with a single wavelength. Moving forward, additional 
chromophore specific excitation wavelengths will be explored. Rather than using UV 
excitation, the infra-red absorption of DNA may be targeted to provide similar histology-like 
contrast while improving in-situ compatibility. Additionally, further excitation wavelengths 
will be added providing selective contrast for biomolecules such as lipids and collagen.  
In addition to adding more chromophore specificity, future works will focus on increasing 
imaging speed. Considering the current system, capturing a single grossing or small region scan 
requires around 12 minutes and provides a 16-megapixel image. This is approximately 60% the 
time required for frozen histology preparation. However, to recover wider swaths such as 
Figure 4a, the scanning time increases linearly with 4 frames requiring 48 minutes. While still 
comparable to frozen sectioning, the PARS imaging time exceeds that of frozen pathology 
depending on how many scans are required. Moving forward, the imaging speed may be 
improved by increasing the point capture/excitation rate. Previous works have reported 
excitation rates of nearly 1 MHz, which if employed, would reduce imaging time to less than 
30 seconds per scan [25]. Concurrently, to avoid mechanical limitations, more efficient 
scanning methods will be implemented. Future work will focus on incorporating these 
improvements aiming to image entire MMS excisions in one capture, with the same area as the 
presented grossing scans (Figure 2), and the same spatial sampling as the presented high-
resolution captures (Figure 3 and Figure 4).  
 
4. Conclusion 
In summary, incorporating the PARS system improvements discussed here have thus far 
enabled an increase in imaging area, repeatability, sensitivity, and resolution. The presented 
results demonstrate the first visualization of nuclear morphology in human tissue samples 
exhibiting BCC, using a non-contact photoacoustic microscopy technique.  Shown here, 
subcellular structures are recovered from entire MMS sections, enabling full tissue margin 
analysis. Concurrently, small regions are captured providing close-ups of clinically relevant 
features such as nuclear organization, density and morphology. The current PARS system 
facilitates recovery of these details more rapidly than conventional processing techniques by 
eliminating tissue processing steps. PARS emulates the contrast provided by common 
histochemical stains, suggesting that if adopted, there may be little requirement to retrain 
pathologists to interpret a new image type. Moreover, the non-contact label-free reflection-
mode PARS microscope presented here, could potentially be applied directly to unprocessed 
MMS excisions. This suggests bulk tissues could be preserved in their entirety enabling re-
examination, further histopathological processing and immunochemistry. Thus, this device 
may circumvent the need for frozen pathology, or could act as an adjunct to the current 
processing stream.  Overall, the PARS modality is well suited to intraoperative guidance of 
MMS and could reduce MMS cycle time, increase patient flow, and free up histopathology staff 
to perform other tasks. Moving forwards, the performance of this system will be examined in 
freshly resected, bulk MMS excisions. 
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